Phio Pharmaceuticals Corp. (PHIO)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 0.7603 |
| Open | 0.8200 |
| Bid | 0.7497 x 100 |
| Ask | 0.8276 x 100 |
| Day's range | 0.7504 - 0.8350 |
| 52-week range | 0.5000 - 5.2900 |
| Volume | |
| Avg. volume | 428,387 |
| Market cap | 3.613M |
| Beta (5Y monthly) | 1.37 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
PHIO Jumps 91% on Encouraging Preclinical Cancer Drug Data
Data from preclinical studies show that Phio's (PHIO) cancer drug PH-894 is effective in BRD4 inhibition for treating various cancer indications like melanoma, breast cancer and lung cancer.
© 2024 Yahoo. All rights reserved.